There has been a significant increase in clinical trial expenses, product development expenses, and professional charges during the last quarter of financial year 2022-23.
There has been a significant increase in clinical trial expenses, product development expenses, and professional charges during the last quarter of financial year 2022-23. There has been a significant increase in clinical trial expenses, product development expenses, and professional charges during the last quarter of financial year 2022-23. Moneycontrol Latest News Read More
हिन्दी 
English